Literature DB >> 9052761

Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells.

J L Baert1, D Monté, E A Musgrove, O Albagli, R L Sutherland, Y de Launoit.   

Abstract

The PEA3 group of transcription factors belongs to the ets family and is composed of 3 known members, PEA3, ERM and ER81, which are more than 95% identical within the DNA-binding ETS domain and exhibit 50% aa identity overall. Recently, transgenic mice bearing the c-erbB-2/neu oncogene have been shown to over-express PEA3 mRNA in mammary adenocarcinomas, suggesting a role for this gene family in mammary tumorigenesis. In the present work we characterized the mRNA expression levels of PEA3-group genes in a series of human epithelial breast cell lines. Each of the 3 genes was highly expressed in normal human HMEC 1001-7 and HMEC 219-4 cells. In breast-cancer cell lines, the 3 genes were highly expressed in the ER- MDA-MB-436, MDA-MB-330, MDA-MB-231 and BT-20 cell lines, but not in the ER+ MDA-MB-134-VI and ZR-75-1 cells. In an attempt to characterize the PEA3-group proteins in breast-cancer cells, we first produced and characterized specific antibodies against each of these 3 proteins. The anti-ERM and anti-ER81 antibodies recognized specific strong bands at approximately 72 kDa and 62 kDa, corresponding to ERM and ER81, respectively, in MDA-MB-231 and Hs-578T cells expressing significant levels of the 3 mRNAs. No protein was detected in MCF-7 cells expressing low levels of mRNA for PEA3-group-family genes, or in ZR-75-1 cells, where mRNA was undetectable by Northern blot. Although in vitro-translated PEA3 is specifically immunoprecipitated by anti-PEA3 anti-serum, we were unable to immunoprecipitate PEA3 protein from MDA-MB-231 and Hs-578T cells. In order to study the transcription factor activity of ERM, PEA3 and ER81 proteins in mammary-cancer cells, we tested their ability to transactivate a reporter plasmid containing 3 Ets-binding sites, and were able to show that, in all the breast-cancer cells tested, transfected ERM, PEA3 and ER81 are able to transactivate. Although the target genes of the PEA3 group of transcription factors in breast-cancer cells have yet to be determined, these genes have a potential role in the regulation of growth and the progression of human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052761     DOI: 10.1002/(sici)1097-0215(19970304)70:5<590::aid-ijc17>3.0.co;2-h

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.

Authors:  Ralph K Lindemann; Melanie Braig; Craig A Hauser; Alfred Nordheim; Jürgen Dittmer
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

Review 2.  Role of Ets transcription factors in mammary gland development and oncogenesis.

Authors:  T Shepherd; J A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

3.  PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells.

Authors:  Z Su; Y Shi; R Friedman; L Qiao; R McKinstry; D Hinman; P Dent; P B Fisher
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

4.  Transcription factor ETV1 is essential for rapid conduction in the heart.

Authors:  Akshay Shekhar; Xianming Lin; Fang-Yu Liu; Jie Zhang; Huan Mo; Lisa Bastarache; Joshua C Denny; Nancy J Cox; Mario Delmar; Dan M Roden; Glenn I Fishman; David S Park
Journal:  J Clin Invest       Date:  2016-10-24       Impact factor: 14.808

5.  Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.

Authors:  S Papoutsopoulou; R Janknecht
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.

Authors:  Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar B Kristensen; Reuven Reich; Juri Kopolovic
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.

Authors:  Basem S Goueli; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

9.  Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.

Authors:  Sonia Netzer; Frauke Leenders; Patrick Dumont; Jean-Luc Baert; Yvan de Launoit
Journal:  Transgenic Res       Date:  2002-04       Impact factor: 2.788

10.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.